Cite
HARVARD Citation
Stern, N. et al. (n.d.). A132 THREE QUARTERS OF INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE INFLIXIMAB THERAPY IN CLINICAL REMISSION SHOW EVIDENCE OF MUCOSAL INFLAMMATION WITH ELEVATED FECAL CALPROTECTIN. Journal of the Canadian Association of Gastroenterology. pp. 229-230. [Online].